Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test SU011248 (sunitinib) in combination with paclitaxel/carboplatin. This combination regimen will be tested for safety and antitumor activity.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07287098 · Breast Neoplasms
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07169851 · Nausea, Vomiting, and more
NCT07258836 · Neoplasms, Healthy
NCT07628998 · Colorectal Neoplasms, Early Detection of Cancer
Pfizer Investigational Site
Detroit, Michigan
Pfizer Investigational Site
Philadelphia, Pennsylvania
Pfizer Investigational Site
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions